| Ytd | -32.21% | |
| 1y | -58.94% |
| Open | 1.01 | Prev Close | 1.01 | Low | 0.98 | High | 1.01 | Mkt Cap | 64.27M |
| Vol | 306.68K | Avg Vol | 359.73K | EPS | -0.32 | P/E | -3.19 | Forward P/E | -13.63 |
| Beta | 0.49 | Short Ratio | 0.57 | Inst. Own | 1.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-08 | 50-d Avg | 1.13 | 200-d Avg | 1.41 | 1yr Est | 3.00 |
TLSA News
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said its CEO Ivor Elrifi increased his stake in the company
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or t
Biotechnology firm Tiziana Life Sciences Ltd. (NASDAQ:TLSA) on Friday revealed promising quantitativ
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has reported imaging results from the third patient with mul
BOSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has reported imaging results from the third patient with mul
BOSTON, July 22, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or t
Qualcomm Inc (NASDAQ:QCOM, XETRA:QCI) outlined higher long-term revenue and earnings targets at its
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said the last patient in its Phase 2a clinical trial has rec
Top line data readout expected in late Q3/early Q4 INFORM-MS trial is a randomized, double-blind, pl
BOSTON, June 15, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or t
BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a b
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said it will present at the Jefferies Global Healthcare Conf
UBS is sticking with a Buy rating on FedEx Corp (NYSE:FDX, XETRA:FDX) and a price target of $445, as
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has completed enrollment in its Phase 2 clinical trial evalu
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has completed enrollment in its Phase 2 clinical trial evalu
Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it has completed patient enrollment in its Ph
3:40pm: Proactive news headlines Tiziana Life Sciences Ltd (NASDAQ:TLSA) completed patient enrollmen
BOSTON, May 21, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a b
Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it has completed patient enrollment in its Ph
Gainers
Gainers
During Tuesday's trading, 505 companies set new 52-week lows.
During Friday's session, 445 companies made new 52-week lows.
On Friday morning, 155 companies achieved new lows for the year.
Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 44.8% to $8.05 after the comp
Gainers Marathon Patent Group, Inc. (NASDAQ: MARA) shares surged 88.7% to close at $3.83 on Mond
Toward the end of trading Monday, the Dow traded up 0.98% to 26688.62 while the NASDAQ rose 1.62% to
Gainers Ambow Education Holding Ltd. (NYSE: AMBO) shares jumped 65.3% to $3.6369.
Midway through trading Monday, the Dow traded up 0.80% to 26638.57 while the NASDAQ rose 1.24% to 10
Movers Indices • S&P 500 ETF (NYSE:SPY) increased 0.60% to $328.35. • Nasdaq ETF (NASDAQ:QQQ)
On Wednesday, 111 companies set new 52-week highs.
Gainers Inari Medical, Inc. (NASDAQ: NARI) shares surged 123.7% to close at $42.51 on Friday afte
Gainers Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) shares jumped 98.40% to $2.5201 after the
Mid-Morning Market Update: Markets Open Higher; Jabil Misses Q2 Estimates